Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
7733 On Other Exchanges
Symbol
Exchange
7733 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

olympus corp (7733) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OLYMPUS CORP (7733)

Related News

No related news articles were found.

olympus corp (7733) Related Businessweek News

View More BusinessWeek News

olympus corp (7733) Details

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates in four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others Business. The Medical Business segment provides endoscopy systems comprising videoscopes, video processors, light sources, and liquid crystal display panels; peripheral equipment, such as image recording devices, endoscope cleaning systems, sterilization systems, etc.; surgical video endoscopy systems, peripheral devices for endoscopic surgery, electrosurgical knives, etc.; and endoscopic devices for various diagnostic and treatment procedures, including biopsy forceps, high-frequency polypectomy snares, grasping forceps, stone retrieval and lithotriptor baskets, hemostasis accessories, etc. The Scientific Solutions Business segment offers upright and polarizing microscopes, inverted microscopes, laser confocal microscopes, box-type fluorescence imaging devices, stereo microscopes, fluorescence macro microscopes, microscope digital cameras, imaging software, bio-imaging systems, and virtual slide systems; and metallurgical microscopes, semiconductor inspection microscopes, laser and measuring microscopes, microscopic 3D measurement systems, industrial videoscopes and fiberscopes, industrial rigid scopes, ultrasonic flaw detectors, eddy current flaw detectors, phased array flaw detectors, X-ray diffraction analyzers, and peripheral equipment. The Imaging Business segment offers digital single-lens cameras, compact digital cameras and related products, digital camera lens barrels, and optical components, as well as IC recorders and binoculars. The Others Business segment manufactures biomedical materials, as well as conducts system development and other business activities. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

31,540 Employees
Last Reported Date: 06/26/15
Founded in 1919

olympus corp (7733) Top Compensated Officers

President and Representative Director
Total Annual Compensation: ¥98.6M
Compensation as of Fiscal Year 2015.

olympus corp (7733) Key Developments

Olympus Corporation Provides Dividend Guidance for the Year Ending March 31, 2016

Olympus Corporation provided dividend guidance for the year ending March 31, 2016. For the year, the company expects year-end dividend of JPY 17.00 per share against JPY 10.00 per share paid a year ago.

Olympus Corporation Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015; Provides Earnings Guidance for the Year Ending March 31, 2016

Olympus Corporation reported consolidated earnings results for the third quarter and nine months ended December 31, 2015. For the nine months, the company reported net sales of JPY 592,541 million against JPY 550,015 million a year ago. Operating income was JPY 73,673 million against JPY 62,068 million a year ago. Ordinary income was JPY 64,715 million against JPY 48,203 million a year ago. Net income attributable to owners of the parent was JPY 42,851 million or JPY 125.17 per share diluted against JPY 31,926 million or JPY 93.27 per share diluted a year ago. Income before provision for income taxes was JPY 46,323 million against JPY 40,750 million a year ago. Capital expenditure was JPY 48,545 million against JPY 27,786 million a year ago. EBITDA was JPY 110,382 million against JPY 98,906 million a year ago. Cash flow from operating activities was JPY 84,910 million against JPY 35,759 million a year ago. Free cash flow was JPY 45,602 million against JPY 14,247 million a year ago. Net debt was JPY 105,419 million against JPY 150,615 million a year ago. For the third quarter, the company reported net sales of JPY 196,767 million against JPY 195,002 million a year ago. Operating income was JPY 23,593 million against JPY 23,642 million a year ago. Ordinary income was JPY 21,217 million against JPY 18,534 million a year ago. Net income attributable to owners of the parent was JPY 7,041 million against JPY 9,595 million a year ago. Income before income taxes and minority interest was JPY 6,859 million against JPY 12,815 million a year ago. Capital expenditure was JPY 16,757 million against JPY 10,366 million a year ago. EBITDA was JPY 35,866 million against JPY 38,522 million a year ago. Cash flow from operating activities was JPY 30,059 million against JPY 6,190 million a year ago. Free cash out flow was JPY 18,210 million against free cash inflow of JPY 1,067 million a year ago. For the full year ending March 31, 2016, the company expects net sales of JPY 816,000 million, operating income of JPY 100,000 million, ordinary income of JPY 86,000 million, net income attributable to owners of the parent of JPY 56,000 million, net income per share of JPY 163.63, income before income taxes and minority interest of JPY 67,600 million, capital expenditure of JPY 69,000 million, depreciation and amortization of JPY 43,000 million and EBITDA of JPY 152,200 million.

Olympus Launches Ergonomic Units for SZX Series Stereo Microscopes

Olympus Corporation has announced that its scientific solutions business has launched three new ergonomic units for the SZX series of stereo microscopes. Three new units help boost productivity and reduce the fatigue associated with microscope use by ensuring that users can adopt a natural pose. Characterized by their ability to provide a three-dimensional image of the specimen, stereo microscopes are widely used in R&D, quality management, and numerous other fields. Olympus supplies the SZX series featuring clear images and comfortable operation, and the SZ series designed for compact size and ease-of-use. The new units are intended for use with the SZX series of stereo microscopes. Using the SZX2-LTTR Ergonomic Long Tilting Trinocular and SZX2-EEPA Extendable Eyepoint Adjuster, users can adjust the viewing angle and height of the stereo microscope. This allows the user to adopt a natural pose, boosting productivity and reducing the fatigue associated with microscope use. Use of a microscope digital camera is also possible using a camera adapter and the SZX2-LTTRAD Extender for Camera Adapter with the Ergonomic Long Tilting Trinocular. To enable each user to adopt a natural pose, the microscope must be capable of being adjusted to suit their stature. Use of the new units enables the viewing angle and height of the stereo microscope to be adjusted for each user. They provide an adjustment range of 5 to 45 for viewing angle and 30 mm to 150 mm for height to suit different users. This helps boost productivity and reduce the fatigue associated with microscope use. Its main products are optical microscopes and industrial videoscopes and non-destructive testing equipment. Through these products, the Scientific Solutions Business helps to keep the infrastructure of society safe and secure, including R&D in the medical, life science, and industrial fields; quality improvement at production facilities; and inspections of aircraft and other large plant, etc.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7733:JP ¥3,795.00 JPY -270.00

7733 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMETEK Inc $45.03 USD -0.59
Hoya Corp ¥3,704 JPY -175.00
Smith & Nephew PLC 1,061 GBp +10.00
St Jude Medical Inc $49.46 USD -1.26
Terumo Corp ¥3,695 JPY -125.00
View Industry Companies
 

Industry Analysis

7733

Industry Average

Valuation 7733 Industry Range
Price/Earnings 100.0x
Price/Sales 1.8x
Price/Book 3.7x
Price/Cash Flow 35.7x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OLYMPUS CORP, please visit www.olympus-global.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.